Metallo-beta-lactamase-producing Pseudomonas aeruginosa in two hospitals from southern Brazil. 2009

Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
Feevale, Laboratory of Biomedicine, Novo Hamburgo, RS.

This study determined the prevalence of metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa in two hospitals located in the Southern part of Brazil and compare the performance of two different phenotypic tests. Thirty-one non-repetitive Pseudomonas aeruginosa isolates from various clinical samples from patients admitted to two hospitals located in Rio Grande do Sul, Brazil (twenty-three from a hospital in Porto Alegre City and eight isolates from a hospital in Vale dos Sinos Region). All strains suggestive of possessing MBLs by phenotypic methods were included in this study. Phenotypic detection of MBLs was carried out simultaneously by using both the MBL Etest and disk approximation test using 2-mercaptopropionic acid close to a ceftazidime disk. Strains positive were further confirmed using molecular techniques for bla(VIM), bla(IMP) and bla(SPM-1). The prevalence of MBLs from samples of inpatients from the hospital located in Porto Alegre was 30.4% and that of inpatients from Vale dos Sinos hospital was only 3.1%. Only MBL type SPM-1 was detected in these samples by molecular analysis and all were detected by the Etest MBL strips. The prevalence of P. aeruginosa that produce MBLs can be markedly different in distinct geographical areas, even among different hospitals in the same area. In our study, the EDTA-based method was the only method able to detect all strains harboring the SPM-1 enzyme.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
January 2008, Indian journal of medical microbiology,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
April 2024, Journal of water and health,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
August 2009, Diagnostic microbiology and infectious disease,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
January 2010, Journal of laboratory physicians,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
January 2011, Indian journal of medical microbiology,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
July 2005, JPMA. The Journal of the Pakistan Medical Association,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
December 2005, The Journal of antimicrobial chemotherapy,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
December 2007, Infection,
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
August 2009, Journal of chemotherapy (Florence, Italy),
Fernanda W Wirth, and Simone U Picoli, and Vlademir V Cantarelli, and Ana L S Gonçalves, and Flávia R Brust, and Liege M O Santos, and Michelle F Barreto
April 2008, The Indian journal of medical research,
Copied contents to your clipboard!